Macrophages are polarised to the M2 phenotype and inhibit CD8+ T cell function after being manipulated by tumour-derived signals, including angiopoietin-2, macrophage-colony-stimulating factor (M-CSF), CCL2, and vascular endothelial growth factor (VEGF) (88, 89). The gene discussed is CD8A; the disease is neoplasm.